| abstract |
This invention relates generally to a novel class of fused heterocyclic compounds of the Formula (I) or Formula (II): n n n or pharmaceutically acceptable salt forms thereof, which are inhibitors of trypsin-like serine protease enzymes, especially factor Xa, pharmaceutical compositions containing the same, and methods of using the same as anticoagulant agents for treatment and prevention of thromboembolic disorders. |